We observed increased lactate and lactylation levels in anthracycline-resistant cancer cells and proposed a novel mechanism by which hyperlactylation of BLM by AARS1 promoted anthracycline resistance by activating HR repair in cancer cells. The gene discussed is BLM; the disease is cancer.